Correlation of Clinical Factors with HMGI(Y), p53 and Ki-67 Expression in Squamous Cell Carcinomas of the Head and Neck
![]() |
Rho Young-Soo
(Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine)
Park Jun-Young (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine) Park Il-Seok (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine) Lim Young-Chang (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine) Moon Sung-Ho (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine) Kim Sung-Dong (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine) Hwang Joon-Sik (Department of Otorhinolayngology-Head and Neck Surgery, Hallym University College of Medicine) Kim Duk-Hwan (Department of Pathology, Hallym University College of Medicine) |
1 | Jones AS, Roland NJ, Caslin AW,Cooke TG : A comparison of cellular proliferation markers in squamous cell carcinoma ofthe head and neck. J Laryngol Otol. 1994 ; 108 : 859-864 PUBMED |
2 | Chiappeta G, Bandiera A, Berlingieri MT, et al : The expression ofthe high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene. 1995 ; 10 : 1307-1314 |
3 | Watling DL, Gown AM, Coltrera MD : Overexpression of p53 in head and neck cancer. Head-Neck. 1992 ; 14 : 437-444 DOI ScienceOn |
4 | Kamel OW, Franklin WA, Ringus JC, Meyer JS : Thymindine labeling index and Ki-67 growth fraction in lesions ofthe breast. Amer J Pathol. 1989 ; 134 : 107-113 |
5 | Friedmann M, Holth LT, Zoghbi HY, Reeves R : Organization, inducible expression, and chromosomal localization ofthe human HMGI-I (Y) nonhistone protein gene. Nucleic Acids Res. 1993 : 21 : 4259-4267 DOI ScienceOn |
6 | Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van de Yen WJ : Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumors. Nature Genet. 1995 ;10 : 436-444 DOI ScienceOn |
7 | VogelsteinB, Fearon ER, Hamilton SR, et al : Genetic alterationsduring colorectal tumor development. N Engl J Med. 1998 ; 319 : 525-532 DOI ScienceOn |
8 | Tamimi Y, van der Poe1HG, Karthaus HFM, Debruyne PM, Schalken JA : A retrospective study of high mobility group protein I (Y) as progression markerfor prostate cancer determined by in situ hybridization. Br J Cancer. 1996 ; 74 : 573-578 DOI PUBMED ScienceOn |
9 | Giancotti V, Pani B, Andrea PD, et al : Elevated levels of specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by contransfection with c-myc audpolyoma middle T genes. Embo J. 1987 ; 6 : 1981-1987 PUBMED |
10 | Rajeswari MR, Singh D, Jain A, Ray R : Elevated levels of high-mobility-group chromosomal proteins, HMGAI, in murine skin carcinoma. Cancer Lett. 2001 ; 173 : 93-99 DOI ScienceOn |
11 | Gerdes J, Li L, Schlueter C, et al : Immunohistochemical and molecular biologic characterization ofthe cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67 study. Am J Pathol. 1991 ; 138 : 867-873 PUBMED |
12 | Gasparini G, Boracchi P, Verderio P : Cell kinetics in human breast cancer .: Comparison between the prognostic value ofthe cytoflurometric S-phase fraction and that ofthe antibodies to Ki67 and PCNA antigens detected by imunocytochemistry. Int J Cancer. 1994 ; 57 : 822-829 |
13 | Zhou X, Benson K, Ashar HR, Chada K : Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature. 1995 ; 376 : 771-774 DOI ScienceOn |
14 | Bandiera A, Bonifacio D, Manfiloletti G, et al : Expression of HMG1 (Y) proteins in squamous intraepithlial and invasive lesions ofthe uterine cervix. Cancer Res. 1998 ; 58 : 426-431 PUBMED |
15 | Levine AJ, Momand J, Finlay CA : The p53 tumor supressor gene. Nature. 1991 ; 351 : 453-456 DOI ScienceOn |
16 | Giancotti V, Buratti E, Perissin L, et al : Analysis of the HMGI nuclear protein in mouse neoplastic cells induced by different procedures. Exp Cell Res. 1989 ; 184 : 538-545 DOI ScienceOn |
17 | Porschen R, Lohe B, Heg1esKJ, Borchard F : Assessment ofcell proliferation in colorectal carcinoma using the monoclonal antibody Ki-67. Cancer. 1989 ; 63 : 1607-1611 DOI ScienceOn |
18 | Hopf NJ, Bremm J, Bohl J, Pemeczky A : Image analysis of proliferating cells in tumors of the human nervous system : an immunohistological study with the monoclonal antibody Ki-67. Neurosurg. 1994 ; 35 : 917-923 DOI ScienceOn |
19 | Fedele M, Bandiera A, Chiappetta G, et al : Human colorectal carcinomas express high levels ofhigh mobility group HMG1 (Y) proteins. Cancer Res. 1996 ; 56 : 1896-1901 PUBMED |
20 | Chiappetta G, Tallini MC, De Biasio G, Manfio1ettiF, MartinezTello FJ, Pentimalli F : Detection of high mobility group I HMGI (Y) proteins in the diagnosis of thyroid tumors : HMGI (Y) expression represents a potential diagnostic indicator of carcinoma. Cancer Res. 1998 ; 58 : 4193-4198 PUBMED |
21 | Kim DH, Park YS, Park CA, Son KC, Nam ES, Shin HS : Expression ofthe HMGI (Y) gene in human colorectal cancer. Int J Cancer. 1999; 84 : 376-380 DOI ScienceOn |
22 | Zhou X, Chada K : HMG1family proteins: architectural transcription factors in mammalian development and cancer. Keio J Med. 1998 ; 47 (2) : 73-77 DOI PUBMED ScienceOn |
23 | Giancotti V, Berlingieri MT, Di Fiore PP, Fusco A, Vecchio G, Crane-Robionson C : Changes in nuclear proteins on transformation of rat epithelial thyroid cells by a murine sarcoma retrovirus. Cancer Res. 1985 ; 45 : 6051-6057 PUBMED |
![]() |